Leadership

We’ve assembled an experienced team with substantial genetic medicines, orphan drug development, and technology development expertise from small and large biopharma companies.
David J. Lockhart, Ph.D.

President & Chief Scientific Officer

Marco Weinberg, Ph.D.

Head of Research

Ariel Kantor, Ph.D.

Senior Vice President, Business and Corporate Development

Max Barker, J.D.

Senior Vice President, Legal Affairs and Business Operations

Erica V. Jefferson

Senior Vice President, Corporate Affairs

Teri Keffer

Senior Vice President, People

Jessica Couch, Ph.D., DABT

Senior Vice President, Early Development

David J. Lockhart, Ph.D.

President & Chief Scientific Officer

Marco Weinberg, Ph.D.

Head of Research

Ariel Kantor, Ph.D.

Senior Vice President, Business and Corporate Development

Max Barker, J.D.

Senior Vice President, Legal Affairs and Business Operations

Erica V. Jefferson

Senior Vice President, Corporate Affairs

Teri Keffer

Senior Vice President, People

Jessica Couch, Ph.D., DABT

Senior Vice President, Early Development

Investors